Medikamentöse Prävention des Mammakarzinoms: Eine Übersicht über die Literatur und den Stand in Deutschland

Keyphrases

• Germany 100%
• Breast Cancer 100%
• Chemoprevention 100%
• Breast Cancer Prevention 100%
• Breast Cancer Risk 60%
• IBIS® 40%
• Medical Intervention 20%
• Meta-analysis 20%
• Mortality Rate 20%
• Odds Ratio 20%
• High Risk 20%
• Mechanism of Action 20%
• Technology Assessment 20%
• Valid Data 20%
• Public Awareness 20%
• Preventive Effect 20%
• Antiestrogen 20%
• GnRH Analogue 20%
• Breast Cancer Treatment 20%
• Incidence Rate 20%
• Postmenopausal Women 20%
• Aromatase Inhibitors 20%
• Accruals 20%
• Breast Cancer in Women 20%
• Tibolone 20%
• Women Participation 20%
• Female Population 20%
• Adjuvant Breast Cancer 20%
• Prevention Trials 20%
• Health Politics 20%
• Retinoids 20%
• Phytoestrogens 20%
• Prevention Studies 20%
• Information Campaign 20%
• Therapeutic Index 20%
• Gynecologist 20%
• Literature Recommendation 20%

Medicine and Dentistry

• Breast Cancer 100%
• Chemoprevention of Breast Cancer 100%
• Chemoprophylaxis 27%
• Tamoxifen 18%
• Medical Intervention 9%
• Meta-Analysis 9%
• Mortality Rate 9%
• Awareness 9%
• Consultation 9%
• Attitude 9%
• Cancer Risk 9%
• Antiestrogen 9%
• Gonadotropin-Releasing Hormone 9%
• Postmenopause 9%
• Aromatase Inhibitor 9%
• Retinoid 9%
• Breast Cancer Prevention 9%
• Technology Assessment 9%
• Phytoestrogen 9%
• Therapeutic Window 9%
• Tibolone 9%
• Odds Ratio 9%

Nursing and Health Professions

• Literature Review 100%
• Breast Cancer 100%
• Chemoprophylaxis 100%
• Tamoxifen 15%
• Meta Analysis 7%
• Odds Ratio 7%
• Gynecologist 7%
• Therapeutic Window 7%
• Mortality Rate 7%
• Cancer Prevention 7%
• Aromatase Inhibitor 7%
• Antiestrogen 7%
• Retinoid 7%
• Phytoestrogen 7%
• Tibolone 7%